Business Context and Reporting Period
Pavmed Inc., an emerging growth company incorporated in Delaware, filed this Form 8-K on April 16, 2019, to report the closing of a portion of a previously announced equity offering.
Key Financial Metrics
- Shares Sold: 1,380,000 shares of common stock closed on April 16, 2019.
- Offering Price: $1.00 per share.
- Remaining Shares: 300,000 shares subscribed, expected to close within one week.
- Total Offering Size: 1,680,000 shares.
- Expected Net Proceeds: Approximately $1.6 million after deducting placement agent fees and offering expenses.
- Use of Proceeds: Working capital, general corporate purposes, and potential repayment of indebtedness.
Material Changes
The filing reports a material capital event: the partial closing of a registered offering. The company has secured subscriptions for the full 1,680,000 shares, with the final tranche of 300,000 shares pending administrative closing.
Outlook and Management Commentary
Management intends to utilize the net proceeds to bolster working capital and address general corporate needs, which may include cash payments on existing debt. Maxim Group LLC served as the exclusive placement agent for institutional investors, while no agent was engaged for select investors. The offering was conducted under an effective shelf registration statement (Form S-3) declared effective on October 6, 2017.
Investor Verification Checklist
- Verify the final closing date and confirmation of proceeds for the remaining 300,000 shares.
- Review the prospectus supplement filed with the SEC for detailed fee structures and dilution impact.
- Confirm the specific allocation of proceeds toward debt repayment versus general working capital.
- Check for any subsequent filings regarding the full closing of the offering.